Literature DB >> 26391864

Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice.

Songpei Li1, Xiao-Yi Zeng1, Xiu Zhou1, Hao Wang1, Eunjung Jo1, Stephen R Robinson1, Aimin Xu2, Ji-Ming Ye3.   

Abstract

The present study investigated the role of dietary cholesterol and fat in the development of nonalcoholic fatty liver disease, a common liver disease in metabolic disorders. Mice were fed a diet of regular chow (CH), chow supplemented with 0.2% w/w cholesterol (CHC), high fat (HF, 45kcal%) or HF with cholesterol (HFC) for 17weeks. While both HF and HFC groups displayed hepatic steatosis and metabolic syndrome, only HFC group developed the phenotype of liver injury, as indicated by an increase in plasma level of alanine transaminase (ALT, by 50-80%). There were ~2-fold increases in mRNA expression of tumor necrosis factor α, interleukin 1β and monocyte chemotactic protein 1 in the liver of HFC-fed mice (vs. HF) but no endoplasmic reticulum stress or oxidative stress was observed. Furthermore, cholesterol suppressed HF-induced increase of peroxisome proliferator-activated receptor γ coactivator 1α and mitochondrial transcription factor A expression and blunted fatty acid oxidation. Interestingly, after switching HFC to HF diet for 5weeks, the increases in plasma ALT and liver inflammatory markers were abolished but the blunted of mitochondrial function remained. These findings suggest that cholesterol plays a critical role in the conversion of a simple fatty liver toward nonalcoholic steatohepatitis possibly by activation of inflammatory pathways together with retarded mitochondrial function.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dietary cholesterol; High fat diet; Inflammation; Mitochondrial function; Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2015        PMID: 26391864     DOI: 10.1016/j.jnutbio.2015.08.021

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  13 in total

1.  Oxidative stress induced by portal vein embolization in fatty liver: Experimental study of a nonalcoholic steatohepatitis model.

Authors:  Yasutaka Baba; Sadao Hayashi; Kohei Nagasato; Michiyo Higashi; Nanako Tosuji; Shunro Sonoda; Takashi Yoshiura
Journal:  Biomed Rep       Date:  2018-08-08

2.  Preventative activity of kimchi on high cholesterol diet-induced hepatic damage through regulation of lipid metabolism in LDL receptor knockout mice.

Authors:  Minji Woo; Mijeong Kim; Jeong Sook Noh; Chan Hum Park; Yeong Ok Song
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

3.  Higher dietary intake of vitamin D may influence total cholesterol and carbohydrate profile independent of body composition in men with Chronic Spinal Cord Injury.

Authors:  Christopher Beal; Ashraf Gorgey; Pamela Moore; Nathan Wong; Robert A Adler; David Gater
Journal:  J Spinal Cord Med       Date:  2017-08-16       Impact factor: 1.985

4.  Cholesterol analysis of Korean eat-out foods for national food composition database.

Authors:  Farhana Sharmin; Beom-Gyun Jeong; Jiyoung Jung; Venus Quines; Jiyeon Chun
Journal:  J Food Sci Technol       Date:  2017-04-12       Impact factor: 2.701

Review 5.  Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease.

Authors:  Ya-Lin Wang; Xiu Zhou; Dong-Li Li; Ji-Ming Ye
Journal:  Acta Pharmacol Sin       Date:  2021-03-17       Impact factor: 6.150

Review 6.  PPARs and Mitochondrial Metabolism: From NAFLD to HCC.

Authors:  Tommaso Mello; Maria Materozzi; Andrea Galli
Journal:  PPAR Res       Date:  2016-12-27       Impact factor: 4.964

7.  Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin.

Authors:  Ali Mahzari; Songpei Li; Xiu Zhou; Dongli Li; Sherouk Fouda; Majid Alhomrani; Wala Alzahrani; Stephen R Robinson; Ji-Ming Ye
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

8.  Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome.

Authors:  Xiu Zhou; Sherouk Fouda; Xiao-Yi Zeng; Dongli Li; Kun Zhang; Jun Xu; Ji-Ming Ye
Journal:  Front Pharmacol       Date:  2019-10-11       Impact factor: 5.810

9.  Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.

Authors:  Yuan Yuan; Hisao Naito; Xiaofang Jia; Kazuya Kitamori; Tamie Nakajima
Journal:  Nutrients       Date:  2017-09-14       Impact factor: 5.717

10.  Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue.

Authors:  Songpei Li; Xiu Zhou; Eunjung Jo; Ali Mahzari; Sherouk Fouda; Dongli Li; Kun Zhang; Ji-Ming Ye
Journal:  Biosci Rep       Date:  2018-12-14       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.